feed,title,long_url,short_url
SeekingAlpha,Cel-Sci's Pivotal Phase 3 Results Are In: The Drama Continues,https://seekingalpha.com/article/4438033,
SeekingAlpha,Windtree Therapeutics: Addressing Underserved And Expensive Acute Conditions,https://seekingalpha.com/article/4438032,
SeekingAlpha,"Tetra Technologies: Knock, Knock, Knocking On The Five Dollar Door",https://seekingalpha.com/article/4438031,
